HES1 oscillations are required for cell cycle reentry in oestrogen receptor–positive breast cancer cells
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2520724123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Oliver Cottrell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Man…. Hauptthemen laut MEDLINE: Transcription Factor HES-1, Breast Neoplasms, Cell Cycle, Receptors, Estrogen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK (CRUK), Wellcome Trust (WT), UKRI | Medical Research Council (MRC).
Abstract (Originalsprache)
Long-term recurrence in breast cancer is driven by reactivation of dormant disseminated tumor cells (DTCs) and remains a major clinical challenge, particularly in estrogen receptor–positive (ER + ) tumors. This process is underpinned by regulation of the cell cycle machinery that controls quiescence maintenance and exit. HES1, a Notch pathway transcription factor, regulates key cell cycle genes and has been shown to demonstrate protein expression oscillations. Here, we sought to establish whether HES1 oscillations may regulate ER+ cancer cell quiescence and reactivation. To investigate this, we developed a fundamental in vitro model of cell cycle arrest and reentry based on reversible CDK4/6 inhibition (CDK4/6i) with palbociclib, compatible with quantitative single-cell live-imaging of a knock-in endogenous HES1 reporter. Consistent with earlier findings, HES1 exhibited ~24 h protein oscillations in cycling cells demonstrating a reproducible dip in protein expression prior to S-Phase. During CDK4/6i-mediated arrest, the ~24 h HES1 oscillation was lost, HES1 levels were maintained at a moderately higher level and HES1 exhibited smaller dips. Similar changes were observed in unperturbed, spontaneously quiescent cells. Following release from CDK4/6i and cell cycle reentry, these alterations were reversed and the characteristic G1/S HES1 dip was observed. Preventing this dip at the point of release, by inducibly sustaining HES1 with a Tet-On system, upregulated the cell cycle inhibitor p21, impeded cell cycle reentry and induced cell death. These findings suggest that manipulating HES1 dynamics could represent a promising therapeutic approach to prevent reactivation of dormant tumor cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PL, United Kingdom.
- Centre for Cancer Cell and Molecular Biology, Barts Cancer Institute, John Vane Science Centre, Charterhouse Square, Queen Mary University of London, London EC1M 6BQ, United Kingdom.
- Safety Science Group, ApconiX, Alderley Edge SK10 4TG, United Kingdom.
- Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Oglesby Cancer Research Building, Manchester M20 4GJ, United Kingd…
ORCID-Profile: Oliver Cottrell, Andrew Rowntree, Nancy Papalopulu
Förderung
- Cancer Research UK (CRUK)
- Wellcome Trust (WT)
- UKRI | Medical Research Council (MRC)
Zitieren
APA
Cottrell, O., Rowntree, A., Chopra, K., Mackellar, E., Noble, B., Dixon, H. L., Healy, C., Clarke, R. B., & Papalopulu, N. (2026). HES1 oscillations are required for cell cycle reentry in oestrogen receptor–positive breast cancer cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2520724123
Vancouver
Cottrell O, Rowntree A, Chopra K, Mackellar E, Noble B, Dixon HL, et al. HES1 oscillations are required for cell cycle reentry in oestrogen receptor–positive breast cancer cells. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2520724123
BibTeX
@article{Cottrell2026,
author = {Cottrell, Oliver and Rowntree, Andrew and Chopra, Kunal and Mackellar, Eleanor and Noble, Benjamin and Dixon, Hannah L and Healy, Ciara and Clarke, Robert B and Papalopulu, Nancy},
title = {HES1 oscillations are required for cell cycle reentry in oestrogen receptor–positive breast cancer cells},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2520724123}
}
EUVIMED